Skip to main content

Phenylbutazone Paste For Horses

This page contains information on Phenylbutazone Paste For Horses for veterinary use.
The information provided typically includes the following:
  • Phenylbutazone Paste For Horses Indications
  • Warnings and cautions for Phenylbutazone Paste For Horses
  • Direction and dosage information for Phenylbutazone Paste For Horses

Phenylbutazone Paste For Horses

This treatment applies to the following species:
Company: Covetrus North America

ANADA 200-266, Approved by the FDA.

APPLE FLAVOR

For animal use only

Each syringe contains 20 g phenylbutazone.

Each 3 mL marking on the plunger contains phenylbutazone: 1 g.

Description

Phenylbutazone Paste is a synthetic, non-hormonal anti-inflammatory, antipyretic compound useful in the management of inflammatory conditions. The apparent analgesic effect is probably related mainly to the compound’s anti-inflammatory properties. Chemically, Phenylbutazone Paste is 4-butyl-1, 2-diphenyl-3, 5-pyrazolidinedione. It is a pyrazolone derivative, entirely unrelated to the steroid hormones.

Phenylbutazone Paste For Horses Indications

For the relief of inflammatory conditions associated with the musculoskeletal system in horses.

Contraindications

Use with caution in patients who have a history of drug allergy.

WARNING: Not for use in horses intended for food.

Precautions

Stop medication at the first sign of gastrointestinal upset, jaundice, or blood dyscrasia. Authenticated cases of agranulocytosis associated with the drug have occurred in man; fatal reactions, although rare, have been reported in dogs after long-term therapy. To guard against this possibility, conduct routine blood counts at weekly intervals during the early phase of therapy and at intervals of two weeks thereafter. Any significant fall in the total white blood cell count, relative decrease in granulocytes, or black or tarry stools should be regarded as a signal for immediate cessation of therapy and institution of appropriate counter-measures. In the treatment of inflammatory conditions associated with infections, specific anti-infective therapy is required.

ADMINISTRATION AND DOSAGE: Orally - 1 to 2 g of phenylbutazone per 500 lb. of body weight daily. Do not exceed 4 g daily.

Guidelines to Successful Therapy: Use a relatively high dose for the first 48 hours, then reduce gradually to a maintenance dose. Maintain the lowest dose capable of producing desired clinical response. Response to Phenylbutazone Paste therapy is prompt, usually occurring within 24 hours. If no significant clinical effect is evident after five days, re-evaluate diagnosis and therapeutic approach.

When administering Phenylbutazone Paste, the oral cavity should be empty. Deposit paste on back of tongue by depressing plunger that has been previously set to deliver the correct dose. Many chronic conditions will respond to Phenylbutazone Paste therapy, but discontinuance of treatment may result in recurrence of symptoms.

Storage

Store at 15°-30°C (59°-86°F).

How Supplied

Syringes containing 20 g of Phenylbutazone.

KEEP OUT OF REACH OF CHILDREN

Phenylbutazone Paste For Horses Caution

Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

Questions? (855) 724-3461

Distributed by: Covetrus North America, 400 Metro Place North, Dublin, OH 43017

covetrus.com

Net volume:

NDC:

Reorder #

 

2.02 fl oz (60 mL)

11695-4858-1

044015

AH-044015-L-01

REV: 0819

CPN: 2050018.0

COVETRUS NORTH AMERICA
400 METRO PLACE NORTH, DUBLIN, OH, 43017
Toll-Free:   1-855-724-3461
Website:   www.covetrus.com
Every effort has been made to ensure the accuracy of the Phenylbutazone Paste For Horses information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2021 Animalytix LLC. Updated: 2021-10-04